Format

Send to

Choose Destination
J Atten Disord. 2015 Jan;19(1):63-71. doi: 10.1177/1087054712452135. Epub 2012 Jul 26.

Do ADHD children with and without child behavior checklist-dysregulation profile have different clinical characteristics, cognitive features, and treatment outcomes?

Author information

1
INSERM U669, University Paris-Sud and University Paris Descartes, Paris, France Robert Debré Hospital, Paris, France peyrehugo@yahoo.fr.
2
INSERM U669, University Paris-Sud and University Paris Descartes, Paris, France Versailles General Hospital. Le Chesnay, France University of Versailles Saint-Quentin-en-Yvelines, Versailles, France.
3
University Hospital, Tours, France New York University Child Study Center, New York, USA INSERM U894, University Paris Descartes, Paris, France.
4
INSERM U894, University Paris Descartes, Paris, France Louis Mourier Hospital, Colombes, France.
5
Robert Debré Hospital, Paris, France INSERM U894, University Paris Descartes, Paris, France.

Abstract

OBJECTIVE:

The Child Behavior Checklist-Dysregulation Profile (CBCL-DP), characterized by elevated scores on the "Attention Problems," "Aggressive Behavior," and "Anxious/Depressed" scales in the CBCL, has been associated with later severe psychopathology. In a sample of children with ADHD, this study sought to further explore the clinical characteristics, the response to methylphenidate medication, and the cognitive features of ADHD children with CBCL-DP.

METHOD:

The sample consisted of 173 ADHD outpatients (age = 10.9 ± 2.81) assessed using symptom severity scales, personality questionnaires (Emotionality Activity Sociability [EAS] and Junior Temperament and Character Inventory [JTCI]), and neuropsychological tests. A subsample of 136 participants was reassessed after optimal adjustment of methylphenidate dosage.

RESULTS AND CONCLUSION:

Variables that were independently associated with CBCL-DP were clinical severity (ADHD Rating Scale [ADHD-RS]), internalized disorders, high emotionality (EAS), and low self-directedness (JTCI). CBCL-DP was associated neither with poorer response to methylphenidate nor with more side effects. There were no differences in cognitive performances between participants with and without CBCL-DP.

KEYWORDS:

CBCL; attention-deficit hyperactivity disorder; methylphenidate; temperament

PMID:
22837549
DOI:
10.1177/1087054712452135
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center